New drug targets for the treatment of cardiovascular disease.
cardiovascular events in new T2D drug development programs. As a result, dedicated cardiovascular safety trials were implemented. Many
The FDA approved a new use for a drug to reduce the risk of cardiovascular disease, heart attack and stroke in adults with cardiovascular
The FDA approved a new use for a drug to reduce the risk of cardiovascular disease, heart attack and stroke in adults with cardiovascular
Drug Classes Cardiovascular Agents Diuretics; Potassium-sparing Diuretics Subscribe to our newsletter for the latest medication news, new drug approvals
Modern medicine has developed new drugs for cardiovascular diseases, such as coronary artery disease and other cardiovascular conditions.
Drug Classes Cardiovascular Agents Diuretics; Potassium-sparing Diuretics Subscribe to our newsletter for the latest medication news, new drug approvals
The FDA approved a new use for a drug to reduce the risk of cardiovascular disease, heart attack and stroke in adults with cardiovascular
In February 2024, Krystexxa was approved which cardiovascular drugs, and supporting research for new cardiovascular drug development.
Comments